Exchange Traded Concepts, LLC Corcept Therapeutics Inc Transaction History

Exchange Traded Concepts, LLC

  • $10.4 Billion
  • Q3 2025

A detailed history of Exchange Traded Concepts, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 1,644 shares of CORT stock, worth $129,218. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,644
Holding current value
$129,218
% of portfolio
0.0%

Shares

21 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2025

Oct 14, 2025
BUY
$67.17 - $83.9 $110,427 - $137,931
1,644 New
1,644 $136,000
Q1 2025

Apr 17, 2025
SELL
$49.85 - $114.22 $17,397 - $39,862
-349 Reduced 3.74%
8,985 $1.03 Million
Q4 2024

Jan 21, 2025
SELL
$44.66 - $60.85 $245,585 - $334,614
-5,499 Reduced 37.07%
9,334 $470,000
Q3 2024

Oct 10, 2024
SELL
$29.51 - $46.26 $1.84 Million - $2.88 Million
-62,213 Reduced 80.75%
14,833 $686,000
Q2 2024

Aug 13, 2024
BUY
$22.21 - $34.48 $301,189 - $467,583
13,561 Added 21.36%
77,046 $2.5 Million
Q1 2024

Apr 15, 2024
BUY
$21.1 - $27.46 $401,680 - $522,756
19,037 Added 42.83%
63,485 $1.6 Million
Q4 2023

Jan 05, 2024
BUY
$24.82 - $32.88 $15,909 - $21,076
641 Added 1.46%
44,448 $1.44 Million
Q3 2023

Oct 18, 2023
BUY
$21.97 - $33.8 $936,910 - $1.44 Million
42,645 Added 3669.97%
43,807 $1.19 Million
Q2 2023

Jul 20, 2023
SELL
$21.44 - $25.15 $493 - $578
-23 Reduced 1.94%
1,162 $25,000
Q1 2023

Apr 12, 2023
SELL
$19.2 - $24.47 $537 - $685
-28 Reduced 2.31%
1,185 $25,000
Q4 2022

Jan 17, 2023
SELL
$19.95 - $29.96 $1,436 - $2,157
-72 Reduced 5.6%
1,213 $25,000
Q3 2022

Oct 07, 2022
BUY
$24.7 - $29.12 $3,976 - $4,688
161 Added 14.32%
1,285 $33,000
Q2 2022

Jul 20, 2022
BUY
$17.33 - $25.3 $1,455 - $2,125
84 Added 8.08%
1,124 $27,000
Q1 2022

Apr 26, 2022
SELL
$16.53 - $25.21 $451,682 - $688,863
-27,325 Reduced 96.33%
1,040 $23,000
Q4 2021

Jan 13, 2022
BUY
$17.1 - $23.34 $15,851 - $21,636
927 Added 3.38%
28,365 $562,000
Q3 2021

Oct 18, 2021
SELL
$19.68 - $22.53 $193,670 - $221,717
-9,841 Reduced 26.4%
27,438 $540,000
Q2 2021

Jul 30, 2021
BUY
$19.97 - $24.43 $81,657 - $99,894
4,089 Added 12.32%
37,279 $820,000
Q1 2021

Apr 20, 2021
SELL
$23.49 - $30.56 $150,359 - $195,614
-6,401 Reduced 16.17%
33,190 $790,000
Q4 2020

Jan 19, 2021
BUY
$16.78 - $27.3 $65,039 - $105,814
3,876 Added 10.85%
39,591 $1.04 Million
Q3 2020

Oct 30, 2020
SELL
$12.46 - $19.98 $23,499 - $37,682
-1,886 Reduced 5.02%
35,715 $622,000
Q2 2020

Jul 15, 2020
BUY
$11.0 - $18.26 $413,611 - $686,594
37,601 New
37,601 $632,000

Others Institutions Holding CORT

# of Institutions
471
Shares Held
83.5M
Call Options Held
489K
Put Options Held
1.02M
View Full List

About CORCEPT THERAPEUTICS INC

CORT Quotes by TradingView
  • Ticker CORT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 107,105,000
  • Market Cap $8.42B
  • Description
  • Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...
More about CORT
Track This Portfolio

Track Exchange Traded Concepts, LLC Portfolio

Follow Exchange Traded Concepts, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Exchange Traded Concepts, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Exchange Traded Concepts, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email